51 completed, 20 unknown, 5 recruiting, 5 withdrawn. 86 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 86 | Completed 51, Unknown 20, Recruiting 5, Withdrawn 5, Terminated 4, Active not recruiting 1 |
Follow Sirolimus: new trials by email Literature Review of Sirolimus trials Research Report on Sirolimus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting ELEVIDYS, Sirolimus, Glucocorticoids - Duchenne Muscular Dystrophy | Phase 4 | Recruiting | Sarepta Therapeutics, Inc. | 20 | 2026-11-30 | 2026-11-12 |
| Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy Cosibelimab, Prednisone, Sirolimus - Cutaneous Squamous Cell Carcinoma, Skin Cancer | Phase 4 | Recruiting | Dana-Farber Cancer Institute | 80 | 2026-04-23 | 2026-08-11 |
| Effect of Sirolimus on Oocyte Quality in Women Undergoing IVF Sirolimus (aka rapamycin) - Oocytes, Oocyte Competence | Phase 4 | Recruiting | Center for Human Reproduction | 20 | 2026-02-25 | 2026-11-13 |
| Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia Sirolimus, Placebo - Antiphospholipid (aPL)-Positive, Thrombocytopaenia | Phase 4 | Recruiting | Peking University First Hospital | 84 | 2025-01-07 | 2026-06-30 |
| The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus Sirolimus - Dilated Cardiomyopathy, Kaposi's Sarcoma-Associated Herpesvirus Infection | Phase 4 | Recruiting | Tongji Hospital | 276 | 2024-01-01 | 2024-02-01 |
| Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients Sirolimus, Mycophenolate mofetil - Kidney Transplantation | Phase 4 | Active not recruiting | Chong Kun Dang Pharmaceutical | 206 | 2021-11-19 | 2026-02-17 |
| Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies Percutaneous sirolimus, Oral sirolimus - Kaposiform Hemangioendothelioma, Tufted Angioma | Phase 4 | Unknown | Children's Hospital of Fudan University | 75 | 2021-10-22 | 2024-03-15 |
| Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. Sirolimus Tab., Mycophenolate Mofetil Cap./Tab. - Kidney Transplantation | Phase 4 | Unknown | Chong Kun Dang Pharmaceutical | 158 | 2021-01-01 | 2021-01-08 |
| Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH) Sirolimus Oral Product, propranolol - Hemangioendothelioma of Liver | Phase 4 | Unknown | Shanghai Children's Medical Center | 36 | 2020-07-01 | 2020-05-29 |
| Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma Sirolimus - Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome | Phase 4 | Completed | Children's Hospital of Fudan University | 30 | 2020-07-01 | 2023-09-26 |
| Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA Sirolimus, Cyclosporine A - Pure Red Cell Aplasia, Acquired | Phase 4 | Completed | Bing Han | 56 | 2020-07-01 | 2023-02-28 |
| Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia sirolimus and ATRA, sirolimus - Autoimmune Anemia | Phase 4 | Withdrawn | Peking Union Medical College Hospital | 2020-04-20 | 2026-07-07 | |
| Immune Monitoring to Facilitate Belatacept Monotherapy Allosure, Immunosuppression reduction, Trugraf - Kidney Transplant Rejection, Immunosuppression | Phase 4 | Completed | Massachusetts General Hospital | 17 | 2020-02-11 | 2023-12-04 |
| Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2) - Hemangioma, Kaposiform Hemangioendothelioma | Phase 4 | Completed | Children's Hospital of Fudan University | 92 | 2019-05-01 | 2023-01-30 |
| Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH sirolimus - Paroxysmal Nocturnal Hemoglobinuria | Phase 4 | Unknown | Peking Union Medical College Hospital | 40 | 2019-04-01 | 2019-03-08 |
| Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome Rapamycin - Peutz-Jeghers Syndrome | Phase 4 | Unknown | Peking Union Medical College Hospital | 10 | 2018-09-16 | 2019-01-23 |
| Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation Rapamycin - Blue Rubber Bleb Nevus Syndrome, Venous Malformation | Phase 4 | Unknown | Peking Union Medical College Hospital | 20 | 2018-07-31 | 2018-12-19 |
| Sirolimus Treatment for Refractory PRCA Sirolimus - Pure Red Cell Aplasia | Phase 4 | Completed | Bing Han | 64 | 2018-02-01 | 2021-07-06 |
| Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis rapamycin - Uterine Fibroids | Phase 4 | Unknown | Peking Union Medical College Hospital | 25 | 2018-01-01 | 2018-04-18 |
| Study of Sirolimus in CTD-TP in China Sirolimus - Connective Tissue Diseases, Thrombocytopenia | Phase 4 | Unknown | Peking Union Medical College Hospital | 20 | 2017-09-21 | 2019-04-17 |
Showing 20 of 86. Sign in to see all of them.
Renal Insufficiency (7) · Kidney Diseases (4) · Graft vs Host Disease (3) · Kaposiform Hemangioendothelioma (3) · Kidney Failure, Chronic (3) · Rejection, Psychology (3) · Skin Neoplasms (3) · Coronary Artery Disease (2) · Coronary Restenosis (2) · Cytomegalovirus Infections (2) · Delayed Graft Function (2) · Hereditary Sensory and Autonomic Neuropathies (2) · Kasabach-Merritt Syndrome (2) · Pulmonary Fibrosis (2) · Red-Cell Aplasia, Pure (2)
Wyeth is now a wholly owned subsidiary of Pfizer (12) · Peking Union Medical College Hospital (6) · Children's Hospital of Fudan University (3) · National Taiwan University Hospital (3) · University Hospital, Basel, Switzerland (3) · Bing Han (2) · Chong Kun Dang Pharmaceutical (2) · Hoffmann-La Roche (2) · Hospital do Rim e Hipertensão (2) · Mayo Clinic (2) · Northwestern University (2) · Seung-Jung Park (2) · University of Cincinnati (2) · University of Maryland, Baltimore (2) · University of Miami (2)
United States (27) · China (15) · South Korea (7) · Germany (6) · Brazil (5) · Canada (5) · Spain (5) · Australia (4) · Switzerland (4) · Taiwan (4) · Argentina (2) · Austria (2) · Belgium (2) · Czechia (2) · France (2)
Kai Li, MD, PhD (2) · Mark D. Stegall, M.D. (2) · Seung-Jung Park, MD, PhD (2) · A. Tarik Kizilisik, M.D. (1) · Abdolreza Haririan, MD, MPH (1) · Adnan Kastrati, MD (1) · Albert Heim, PD Dr. (1) · Aleksandra Kukula, MD (1) · Alfredo E Rodriguez, MD PhD FACC (1) · Anke Schwarz, Prof. Dr. (1)
PMID 19208097, PMID 19670189, PMID 24363761, PMID 26504182, PMID 27881371, PMID 10221490, PMID 10798738, PMID 12438948, PMID 12761269, PMID 14742989, PMID 14742990, PMID 15302787, PMID 15660173, PMID 15899725, PMID 16468960, PMID 16570006, PMID 18431244, PMID 18497677, PMID 19714613, PMID 19926058, PMID 19926370, PMID 20449934, PMID 20833822, PMID 21401720, PMID 21981661, PMID 22109997, PMID 22420843, PMID 22776430, PMID 23140536, PMID 23370547, PMID 24266855, PMID 25083614, PMID 26465152, PMID 26817280, PMID 28810721, PMID 29982851, PMID 31561278, PMID 32022990, PMID 32030447, PMID 33200217, PMID 37046380, PMID 37160872, PMID 37525373, PMID 38481209, PMID 40197799
2004 (1)